← Back
Partner
Biotechnology
About this partner
LEAH Labs is bringing cell therapies to dogs.
Enabled by precision gene editing, we aim to use naturally occurring disease in dogs to iterate on and improve CAR-T cell therapy, while first targeting canine B cell lymphoma, a clinical analog of the CAR-T curable non-Hodgkin's lymphoma in humans.
Related news